| Convergent antibody responses to SARS-CoV-2 in convalescent individuals DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ... Nature 584 (7821), 437-442, 2020 | 1985 | 2020 |
| Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021 | 1692 | 2021 |
| mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants Z Wang, F Schmidt, Y Weisblum, F Muecksch, CO Barnes, S Finkin, ... Nature 592 (7855), 616-622, 2021 | 1482 | 2021 |
| Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ... elife 9, e61312, 2020 | 1470 | 2020 |
| Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection Z Wang, F Muecksch, D Schaefer-Babajew, S Finkin, C Viant, C Gaebler, ... Nature 595 (7867), 426-431, 2021 | 735 | 2021 |
| MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation Y Dorsett, KM McBride, M Jankovic, A Gazumyan, TH Thai, DF Robbiani, ... Immunity 28 (5), 630-638, 2008 | 598 | 2008 |
| Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ... Journal of Experimental Medicine 217 (11), e20201181, 2020 | 560 | 2020 |
| Enhanced SARS-CoV-2 neutralization by dimeric IgA Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ... Science translational medicine 13 (577), eabf1555, 2021 | 420 | 2021 |
| Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice A Halper-Stromberg, CL Lu, F Klein, JA Horwitz, S Bournazos, L Nogueira, ... Cell 158 (5), 989-999, 2014 | 418 | 2014 |
| Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5 R Pavri, A Gazumyan, M Jankovic, M Di Virgilio, I Klein, ... Cell 143 (1), 122-133, 2010 | 415 | 2010 |
| Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo CL Lu, DK Murakowski, S Bournazos, T Schoofs, D Sarkar, ... Science 352 (6288), 1001-1004, 2016 | 363 | 2016 |
| A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges R Gautam, Y Nishimura, A Pegu, MC Nason, F Klein, A Gazumyan, ... Nature 533 (7601), 105-109, 2016 | 358 | 2016 |
| Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques M Shingai, OK Donau, RJ Plishka, A Buckler-White, JR Mascola, ... Journal of Experimental Medicine 211 (10), 2061-2074, 2014 | 354 | 2014 |
| Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico DF Robbiani, L Bozzacco, JR Keeffe, R Khouri, PC Olsen, A Gazumyan, ... Cell 169 (4), 597-609. e11, 2017 | 346 | 2017 |
| 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination A Bothmer, DF Robbiani, N Feldhahn, A Gazumyan, A Nussenzweig, ... Journal of Experimental Medicine 207 (4), 855-865, 2010 | 344 | 2010 |
| Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice A Escolano, JM Steichen, P Dosenovic, DW Kulp, J Golijanin, D Sok, ... Cell 166 (6), 1445-1458. e12, 2016 | 325 | 2016 |
| Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... Journal of Experimental Medicine 218 (3), e20201993, 2020 | 311 | 2020 |
| Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice P Dosenovic, L von Boehmer, A Escolano, J Jardine, NT Freund, AD Gitlin, ... Cell 161 (7), 1505-1515, 2015 | 298 | 2015 |
| Early antibody therapy can induce long-lasting immunity to SHIV Y Nishimura, R Gautam, TW Chun, R Sadjadpour, KE Foulds, M Shingai, ... Nature 543 (7646), 559-563, 2017 | 293 | 2017 |
| B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity J Qian, Q Wang, M Dose, N Pruett, KR Kieffer-Kwon, W Resch, G Liang, ... Cell 159 (7), 1524-1537, 2014 | 275 | 2014 |
